Citius Pharmaceuticals In... (CTXR)
NASDAQ: CTXR
· Real-Time Price · USD
1.23
-0.15 (-10.87%)
At close: Aug 19, 2025, 3:59 PM
1.23
0.41%
Pre-market: Aug 20, 2025, 08:00 AM EDT
Citius Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Net Income | -43.44M | -40.48M | -39.43M | -38.29M | -36.2M | -38.18M | -32.54M | -30.59M | -30.97M | -28.01M | -33.64M | -30.61M | -27.57M | -24.13M | -23.05M | -22.21M | -21.07M | -21.37M |
Depreciation & Amortization | 217.38K | 213.44K | 209.61K | 205.9K | 202.06K | 198.14K | 194.32K | 190.6K | 186.93K | 183.25K | 179.68K | 176.19K | 172.53K | 168.65K | 164.87K | 161.23K | 150.58K | 157.44K |
Stock-Based Compensation | 10.93M | 11.31M | 11.84M | 12.27M | 10.39M | 8.47M | 6.62M | 4.52M | 4.35M | 4.2M | 3.91M | 3.39M | 2.76M | 2.08M | 1.45M | 1.24M | 1.04M | 859.46K |
Other Working Capital | 8.2M | 2.66M | -3.68M | -2.72M | -5.39M | -2.73M | -5.77M | -5.31M | -2.37M | -5.66M | 351.27K | -1.02M | -773.03K | 1.74M | -2.14M | -917.61K | -1.11M | -890.94K |
Other Non-Cash Items | 109.95K | 3.37M | 3.44M | 6.77M | 7.58M | 4.42M | 5.27M | 2.05M | 2.24M | 2.31M | 1.49M | 1.22M | 342.48K | 232.48K | -735.47K | -468.91K | -681.31K | -443.29K |
Deferred Income Tax | 816.48K | 696.24K | 576K | 576K | 576K | 576K | 576K | 1.01M | -244.98K | -388.98K | -532.98K | -1.11M | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 7.82M | 1.26M | -1.69M | -4.14M | -5.44M | -1.62M | -4.01M | -3.93M | -1.35M | -5.91M | 239.56K | -683.46K | -200.78K | 2.55M | -2.72M | -1.37M | -1.5M | -1.45M |
Operating Cash Flow | -23.55M | -26.79M | -28.2M | -29.09M | -30.3M | -30.37M | -29.06M | -28.59M | -26.72M | -28.53M | -28.36M | -27.62M | -24.73M | -19.34M | -24.25M | -22.02M | -21.18M | -21.38M |
Capital Expenditures | -8 | -4 | -4 | -4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -40M | -40.01M | -40.01M | -40.01M | -6.94K | -1.83K | -1.83K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -5M | -5M | -5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -40M | -40M | -40M | -40M | n/a | n/a | n/a |
Investing Cash Flow | -5M | -5M | -5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -40M | -40.01M | -40.01M | -40.01M | -6.94K | -1.83K | -1.83K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 9.89M | 9.89M | 9.89M | 13.72M | 13.8M | 13.83M | 13.83M | 13.83M | 31.27K | n/a | n/a | -31.04M | -14.24M | n/a | n/a | 31.04M | 15.54M | 7.32M |
Financial Cash Flow | 16.01M | 12.55M | 9.97M | 13.72M | 13.8M | 13.83M | 13.83M | 13.83M | 31.27K | n/a | n/a | -120.47M | -103.67M | -500 | n/a | 129.17M | 120.54M | 22.9M |
Net Cash Flow | -12.53M | -19.25M | -23.23M | -15.37M | -16.51M | -16.54M | -15.23M | -14.76M | -26.69M | -28.53M | -28.36M | -67.62M | -47.94M | 61.13M | 56.21M | 107.15M | 99.36M | 1.52M |
Free Cash Flow | -23.55M | -26.79M | -28.2M | -29.09M | -30.3M | -30.37M | -29.06M | -28.59M | -26.72M | -28.53M | -28.36M | -67.62M | -64.74M | -59.34M | -64.26M | -22.02M | -21.19M | -21.38M |